Form 8-K - Current report:
SEC Accession No. 0001213900-25-051144
Filing Date
2025-06-04
Accepted
2025-06-04 16:01:45
Documents
12
Period of Report
2025-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea024460401-8k_abvcbio.htm   iXBRL 8-K 42307
  Complete submission text file 0001213900-25-051144.txt   207731

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20250603.xsd EX-101.SCH 3038
3 XBRL LABEL FILE abvc-20250603_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE abvc-20250603_pre.xml EX-101.PRE 22374
14 EXTRACTED XBRL INSTANCE DOCUMENT ea024460401-8k_abvcbio_htm.xml XML 3570
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 251023043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)